# Minerva Neurosciences, Inc. (NERV)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NERV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -125.40M | $ -5.43B | $ 64.96M | $ -254.01M |
| 2025 | $ 0 | $ -300.44M | $ -9.66M | $ 0 | $ -140.75M |
| 2024 | $ 0 | $ 1.51M | $ -20.55M | $ 0 | $ -25.69M |
| 2023 | $ 0 | $ -32.44M | $ -15.99M | $ 0 | $ -28.46M |
| 2022 | $ 0 | $ -35.87M | $ -27.55M | $ 0 | $ -20.02M |
| 2021 | $ 0 | $ -59.32M | $ -29.24M | $ 0 | $ 7.98M |
| 2020 | $ 52.46M | $ 2.47M | $ -43.09M | $ 111.2K | $ 52.66M |
| 2019 | $ 0 | $ -93.17M | $ -56.06M | $ 284.1K | $ 27.78M |
| 2018 | $ 0 | $ -66.26M | $ -55.39M | $ 0 | $ 90.26M |
| 2017 | $ 0 | $ -42.47M | $ 4.17M | $ 3.96M | $ 131.60M |
| 2016 | $ 0 | $ -42.71M | $ -35.34M | $ 8.69M | $ 105.98M |
| 2015 | $ 0 | $ -38.02M | $ -34.08M | $ 9.94M | $ 55.32M |
| 2014 | $ 0 | $ -80.40M | $ -50.83M | $ 0 | $ 51.50M |
| 2013 | $ 0 | $ -4.64M | $ -3.08M | $ 58.3K | $ 20.18M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.26 |
| Liabilities / Eq | -1.37 |
| Current Ratio | 17.65 |

## Other views

- [Metrics](https://sponda.capital/en/NERV.md)
- [Charts](https://sponda.capital/en/NERV/charts.md)
- [Compare](https://sponda.capital/en/NERV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.